Mounjaro price guide in Japan
How to compare medication price, consultation fees, delivery fees and long-plan conditions.
Home > Mounjaro
Once-weekly injection / dual GIP and GLP-1 receptor agonistMounjaro Online Consultation Hub: 2.5mg, 5mg, 7.5mg and 10mg
A comprehensive English hub for Mounjaro (tirzepatide) 2.5mg, 5mg, 7.5mg and 10mg, covering dose positioning, prices, side effects, online consultation, pharmacy counseling, delivery and detailed related articles.
Key points first
2.5mg–10mg
Escalation is not automatic. If the current dose is effective and tolerated, it may be continued.
2026-08-06
In Japan, Mounjaro is approved for type 2 diabetes. Use for weight management in private care is off-label.
How the 2.5mg-to-10mg dose pathway is considered
2.5mg
Common starting dose used to assess tolerability.
5mg
Usual maintenance dose considered after four weeks at 2.5mg.
7.5mg
Intermediate step considered after at least four weeks when 5mg is insufficient.
10mg
Higher dose considered when 7.5mg remains insufficient and tolerability is acceptable.
Escalation is not automatic. If the current dose is effective and tolerated, it may be continued.
Price table
| Dose | 1 month | 3 months | 6 months |
|---|---|---|---|
| 2.5mg | ¥11,800 | ¥31,800 | ¥61,800 |
| 5mg | ¥18,800 | ¥51,800 | ¥99,800 |
| 7.5mg | ¥29,800 | ¥79,800 | ¥144,800 |
| 10mg | ¥37,800 | ¥97,800 | ¥179,800 |
How to interpret clinical-trial evidence for 10mg
SURMOUNT-1 was a 72-week trial in adults with obesity or overweight without diabetes. Mean body-weight change in the 10mg group was −19.5%. This was a controlled trial with defined participants, lifestyle intervention and follow-up, and it does not predict an individual result.
The chart visualizes group means reported in the paper. It does not predict an individual response at each dose.
The SURPASS program also evaluated tirzepatide doses including 10mg in people with type 2 diabetes. Obesity and diabetes trials have different populations and objectives, so their results should not be treated as interchangeable.
Safety and adverse effects
Common adverse effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort and reduced appetite. Gastrointestinal events are reported more often during dose escalation.
From consultation to delivery
- Complete an online medical consultation
- If prescribed, information is sent to a partner pharmacy
- The pharmacy contacts you to arrange medication counseling
- Complete online counseling and pay the pharmacy
- Collect the medicine or receive delivery within Japan
Mounjaro guides and articles
Long-term use of Mounjaro 7.5mg
When continuing 7.5mg may be reasonable and when 10mg may be considered.
When to move from 7.5mg to 10mg
Key checks before escalation: duration, response, adverse effects and medical review.
Mounjaro side effects
Nausea, constipation, diarrhea, vomiting and signs that need medical attention.
Who responds to Mounjaro?
How diet, activity, sleep, constipation and fluid shifts affect apparent response.
Restarting Mounjaro
Why restart dose depends on the treatment gap, previous dose and adverse effects.
Mounjaro and pregnancy
Considerations for pregnancy planning, pregnancy and breastfeeding.
Muscle and lean mass during treatment
Practical guidance on protein intake and resistance training during weight loss.
Eating out while using Mounjaro
How to choose meals when appetite and portion size are reduced.
Convenience-store food choices
Ways to secure protein and fluids with smaller meals.
Frequently asked questions
Can everyone use 10mg?
No. It may be considered after adequate use of 7.5mg when response remains insufficient, adverse effects are acceptable and a doctor judges escalation appropriate.
Does a higher dose always mean better results?
No. Additional benefit varies and must be balanced against tolerability. If the current dose is effective, escalation may not be needed.
What are the 10mg prices?
¥37,800 for 1 month, ¥97,800 for 3 months and ¥179,800 for 6 months. Shipping is separate.
Is Mounjaro approved in Japan for weight management?
In Japan, Mounjaro is approved for type 2 diabetes. Use for weight management in private care is off-label and requires individual medical assessment and explanation.
Are side effects more common during escalation?
Nausea, vomiting and diarrhea are reported more often during dose escalation and may decrease over time, but significant symptoms require medical review.